- Open Access
Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
Journal of Hematology & Oncology volume 14, Article number: 61 (2021)
Correction to: Journal of Hematology & Oncology (2016) 9:93 https://doi.org/10.1186/s13045-016-0327-5
The original article  contains an error in Fig. 4b, the panel of colonies of 5 µM Ara-C treatment was unintentionally duplicated onto the colonies of 2.5 µM alantolactone treatment. The error was mistakenly introduced in image integration when organizing the figures. However, the error has no bearing on the work’s scientific conclusions as the statistical results are based on the correct pictures. The authors apologize to the editor and readership of Journal of Hematology & Oncology for any inconvenience caused.
Ding Y, Gao H, Zhang Y, Li Y, Vasdev N, Gao Y, Chen Y, Zhang Q. Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol. 2016;9:93.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ding, Y., Gao, H., Zhang, Y. et al. Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol 14, 61 (2021). https://doi.org/10.1186/s13045-021-01069-3